DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis.

Yongwen LuoZhiwen HeWei LiuFenfang ZhouTao LiuGang Wang

Published in: Oxidative medicine and cellular longevity (2022)

Increased DTL expression was correlated with malignant biological behavior and poor prognosis of BCa patients, and it may promote BCa progression through the AKT/mTOR pathway. Our research provided a potential predictor and therapeutic target for BCa.

Keyphrases

poor prognosis
cell proliferation
long non coding rna
end stage renal disease
signaling pathway
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis